*MZ Toutiao (美妆头条) · 2026-10-27 · MedTech / Investment* **原文：** 拿下国内首张眼周射频三类证，英睿迪再获数千万融资 Yingruidi (英睿迪), a Shanghai medical-device company founded in 2021, has closed a Pre-A+ round of “tens of millions of RMB” from the Taicang Loudong Fund and the Taicang Beauty Industry Fund, according to company registry data cited by MZ Toutiao. The money goes into a radiofrequency manufacturing base in Taicang, promotion of its BeaShape device, trials for additional indications and post-procedure skincare. Yingruidi already assembles machines and consumables at a Zaozhuang plant; the Taicang site is meant to consolidate R and D with production so the whole chain sits in-house. What makes the round legible is the certificate. In June 2026 the NMPA cleared BeaShape as a class III radiofrequency skin-treatment device for periorbital ageing — the first in China approved specifically for eye-contour wrinkles, a niche clinics had been serving with general-purpose machines. Since 1 April 2026 radiofrequency treatment devices have formally been class III, so unregistered units cannot be made, imported or sold. Capital is now pricing registration and clinical data instead of traffic, and the company s

相关内容